Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase 2 Clinical Trial-Dehydroepiandrosterone in Monoclonal Gammopathy-261065125
Mayo Clinic, Rochester, Rochester, MN, United States
Search grants from Mayo Clinic, Rochester
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Invasive aspergillosis complicating severe influenza
Strenghthening HIV Testing Care & Support Services Focused on Marp's
Mechanism and Control of Urea Biosynthesis
Minority Honors Undergraduate Research Training
Membrane Phosphorylation and Hepatic Growth
Recently added grants:
Racial and ethnic disparities in access to kidney transplantation.
Nutrient sensing O-GlcNAcylation in pituitary development
Treating Brain Swelling in Pediatric Cerebral Malaria
Biosynthesis and medicinal chemistry of the capuramycin antimycobacterial antibiotics
Equity and Economic Effects of MTM Services
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN065125-002
Application #
7191414
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2005
Total Cost
Indirect Cost
Institution
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
City
Rochester
State
MN
Country
United States
Zip Code
55905
Related projects
NIH 2005
N01 CN
Phase 2 Clinical Trial-Dehydroepiandrosterone in Monoclonal Gammopathy-261065125
/ Mayo Clinic, Rochester
NIH 1996
N01 CN
Phase II Clinical Trial Dehydroepiandrosterone
Lust, John Anthony / Mayo Clinic, Rochester
Comments
Be the first to comment on this grant